Expanding Horizons: Xentria Achieves Milestone Success with Biosimilar Development

Xentria announces operational milestone with expansion of multiple clinical trials in 11 countries and 3 regions across their portfolio. Advancements in operational infrastructure allows for further portfolio growth to develop therapeutics and address unmet medical needs. CHICAGO, Jan. 8,…